Skip to content
Trial Eligibility
Menu

Crohn's Disease Clinical Trials near Dallas, TX

21 studies for Crohn's Disease are recruiting at 47 sites within 50 miles of Dallas, Texas, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near Dallas.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Crohn's Disease studies enrolling near Dallas

Showing 21 studies, nearest first.
  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UT Southwestern Simmons Cancer Center - RedBird (Dallas, TX); UT Southwestern/Simmons Cancer Center-Dallas (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  2. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    NCT06430801

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Baylor University Medical Center ( Site 5031) (Dallas, TX); GI Alliance - Southlake ( Site 5109) (Southlake, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  3. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

    NCT07196722

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baylor University Medical Center (Dallas, TX); UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  4. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

    NCT06045754

    • Phase 4
    • Ages 18 to 70 years
    • Sex: All

    Nearest sites: GI Alliance - Digestive Health Associates of Texas (Dallas, TX); Texas Digestive Disease Consultants (TDDC), Southlake (Southlake, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  5. A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819891

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: University of Texas Southwestern Medical Center - Multidisciplinary Spine Clinic - James W. Aston Ambulatory Care Center (Dallas, TX); GI Alliance (Garland, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  6. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    NCT07113522

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Mirador Therapeutics Selected Site (Dallas, TX); Mirador Therapeutics Selected Site (Garland, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  7. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184931

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: The University of Texas Southwestern Medical Center-Site Number: 8400098 (Dallas, TX); SMS Clinical Research-Site Number: 8400035 (Mesquite, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  8. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    NCT05230173

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Texas Southwestern (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

    NCT06456593

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Baylor University Hospital (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Standardized Microbiota Transplant Therapy in Crohn's Disease

    NCT06631586

    • Phase 2
    • Ages 18 to 89 years
    • Sex: All

    Nearest site: UT Southwestern (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819878

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: SMS Clinical Research, LLC (Mesquite, TX); Texas Clinical Research Institute, LLC (Arlington, TX)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  12. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184944

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: SMS Clinical Research-Site Number: 8400035 (Mesquite, TX); Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake-Site Number: 8400101 (Southlake, TX)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    NCT07499232

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: DFW Clinical Trials (Carrollton, TX)

    Distance to nearest recruiting site
    ~13 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    NCT07697456

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: GI Alliance -Garland /ID# 284253 (Garland, TX); Texas Digestive Disease Consultants - Southlake /ID# 283931 (Southlake, TX)

    Distance to nearest recruiting site
    ~13 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  15. Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

    NCT06651281

    • Phase 3
    • Ages Any age
    • Sex: All

    Nearest sites: GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290) (Garland, TX); GI Alliance - Southlake ( Site 0298) (Southlake, TX)

    Distance to nearest recruiting site
    ~13 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

    NCT06226883

    • Phase 2
    • Ages 18 to 85 years
    • Sex: All

    Nearest sites: Prime Clinical Research - Lewisville (Lewisville, TX); Prime Clinical Research (Mansfield, TX)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

    NCT04844606

    • Phase 3
    • Ages 2 to 19 years
    • Sex: All

    Nearest site: Cook Children's Medical Center (Fort Worth, TX)

    Distance to nearest recruiting site
    ~30 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

    NCT05509777

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Cook Children's Medical Center (Fort Worth, TX)

    Distance to nearest recruiting site
    ~30 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

    NCT05923073

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Cook Childrens Medical Center (Fort Worth, TX)

    Distance to nearest recruiting site
    ~30 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

    NCT06663332

    • Phase 3
    • Ages 3 years and older
    • Sex: All

    Nearest site: Cook Childrens Medical Center (Fort Worth, TX)

    Distance to nearest recruiting site
    ~30 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease

    NCT07683325

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: GI Alliance - Fort Worth (Fort Worth, TX)

    Distance to nearest recruiting site
    ~30 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Crohn's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.